Gian Lifecare Ltd

Gian Lifecare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gian Lifecare Ltd

₹ 19.0 1.98%
22 Nov - close price
gianpathlabs.com BSE: 542918
About

Incorporated in 2018, Kanpur (UP) based Gian Life Care Limited is engaged in the business of providing diagnostic and related healthcare services. The company caters to individual patients, hospitals, corporates and other healthcare providers.

Key Points

Business Overview:[1]
Company provides diagnostic and related
healthcare tests and services in Kanpur
and nearby areas. Company provides diagnostic and related healthcare tests and services viz. patient diagnosis, prevention and wellness diagnosis services to its patients and healthcare providers. Company is in process to open several diagnostics labs in various parts of country. Another major lab in Lucknow also became operational in April, 2022

Website BSE
  • Market Cap ₹ 19.7 Cr.
  • Current Price ₹ 19.0
  • High / Low ₹ 29.0 / 17.0
  • Stock P/E 5.05
  • Book Value ₹ 18.8
  • Dividend Yield 0.00 %
  • ROCE 28.7 %
  • ROE 24.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 1.01 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -0.83%
  • Promoter holding is low: 32.0%
  • Promoters have pledged 62.3% of their holding.
  • Debtor days have increased from 94.5 to 137 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
6.12 2.47 2.47 2.82 5.09 1.55 2.43 2.30 3.79 4.60 1.98 1.95
2.15 4.02 2.50 2.40 2.83 2.31 1.92 1.97 1.59 1.55 1.76 1.74
Operating Profit 3.97 -1.55 -0.03 0.42 2.26 -0.76 0.51 0.33 2.20 3.05 0.22 0.21
OPM % 64.87% -62.75% -1.21% 14.89% 44.40% -49.03% 20.99% 14.35% 58.05% 66.30% 11.11% 10.77%
0.07 0.29 0.17 0.34 0.17 0.18 0.14 0.15 0.19 0.18 0.19 0.17
Interest 0.05 0.21 0.10 0.10 0.12 0.11 0.12 0.11 0.14 0.10 0.14 0.12
Depreciation 0.08 0.09 0.12 0.11 0.14 0.12 0.13 0.13 0.16 0.11 0.12 0.12
Profit before tax 3.91 -1.56 -0.08 0.55 2.17 -0.81 0.40 0.24 2.09 3.02 0.15 0.14
Tax % 25.06% -25.00% 0.00% 16.36% 13.82% 17.28% 35.00% 16.67% 25.36% 29.47% 40.00% 14.29%
2.92 -1.17 -0.08 0.46 1.86 -0.95 0.26 0.20 1.55 2.13 0.09 0.12
EPS in Rs 2.83 -1.13 -0.08 0.44 1.80 -0.92 0.25 0.19 1.50 2.06 0.09 0.12
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 TTM
15.45 11.41 12.78 12.32
9.39 9.56 6.63 6.64
Operating Profit 6.06 1.85 6.15 5.68
OPM % 39.22% 16.21% 48.12% 46.10%
0.51 0.69 0.67 0.73
Interest 0.39 0.45 0.54 0.50
Depreciation 0.33 0.50 0.53 0.51
Profit before tax 5.85 1.59 5.75 5.40
Tax % 25.30% 33.33% 27.65%
4.37 1.06 4.15 3.89
EPS in Rs 4.23 1.02 4.01 3.77
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 184%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -26%
1 Year: -3%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 10.34 10.34 10.34 10.34
Reserves 3.69 4.78 8.93 9.15
2.03 4.57 4.88 4.71
7.00 8.56 8.48 10.15
Total Liabilities 23.06 28.25 32.63 34.35
3.50 4.62 5.07 4.84
CWIP 0.12 0.14 0.14 0.14
Investments 0.00 0.00 0.00 0.00
19.44 23.49 27.42 29.37
Total Assets 23.06 28.25 32.63 34.35

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
5.79 2.22 0.70
-4.12 -0.94 -0.32
0.67 -0.37 -0.16
Net Cash Flow 2.34 0.91 0.22

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Debtor Days 42.05 103.97 137.37
Inventory Days
Days Payable
Cash Conversion Cycle 42.05 103.97 137.37
Working Capital Days -31.66 -67.82 -7.14
ROCE % 11.41% 28.70%

Shareholding Pattern

Numbers in percentages

9 Recently
Mar 2021Sep 2021Mar 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
69.87% 69.87% 64.95% 60.77% 60.68% 56.90% 53.10% 53.10% 51.73% 48.47% 32.82% 31.99%
30.13% 30.13% 35.05% 39.22% 39.33% 43.10% 46.90% 46.90% 48.26% 51.53% 67.18% 68.01%
No. of Shareholders 61822844965261,0891,3362,0982,0922,4263,3493,863

Documents

Announcements

Annual reports

Concalls

  • Nov 2021
    Transcript
    Notes
    PPT